Stock listing

NASDAQ:TENX Tenax Therapeutics, Inc. Stock

Home listing (NASDAQ) of Tenax Therapeutics, Inc.

Follow Tenax Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TENX

$1.69 USD +0.06 (+3.7%)

Close on Nov 6, 2026

Past year -75.6% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$1.62 – $1.72 USDNov 6, 2026
Volume
783,312 sharesNov 6, 2026
Market cap
$63.25M USDAt the close on Nov 6, 2026 · price × 37.42M shares outstanding
52-week range
$1.31 – $19.40 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$10.22M USDMedian day 2.43M shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Tenax Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TENX · Home$1.69 USD+0.06 (+3.7%)783,312$1.64$1.715$1.62$1.63Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:TENX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.69+0.06+3.7%$1.64$1.715$1.62783,312
$1.63-0.18-9.9%$1.77$1.77$1.5711,942,947
$1.81-0.03-1.6%$1.85$1.88$1.7351,241,546
$1.84+0.04+2.2%$1.81$1.92$1.792,487,880
$1.80+0.01+0.6%$1.83$1.84$1.771,161,006
$1.79-0.07-3.8%$1.83$1.85$1.73868,294
$1.86-0.02-1.1%$1.86$2.01$1.812,453,314
$1.88+0.16+9.3%$1.72$1.89$1.6861,649,845
$1.72+0.08+4.9%$1.62$1.76$1.601,669,194
$1.64-0.08-4.7%$1.72$1.74$1.621,261,169
$1.72-0.04-2.3%$1.76$1.76$1.69852,000
$1.76+0.13+8.0%$1.74$1.836$1.643,296,100
$1.630.000.0%$1.65$1.70$1.6152,353,300
$1.63+0.11+7.2%$1.50$1.64$1.501,455,700
$1.52+0.16+11.8%$1.41$1.54$1.412,578,800
$1.36-0.15-9.9%$1.51$1.52$1.361,859,200
$1.51-0.025-1.6%$1.55$1.56$1.512,009,000
$1.535-0.065-4.1%$1.60$1.65$1.531,955,800
$1.60-0.23-12.6%$1.84$1.84$1.587,683,600
$1.83-0.04-2.1%$1.88$1.88$1.83789,200
$1.87+0.01+0.5%$1.86$1.91$1.802,344,800
$1.86-0.05-2.6%$1.91$1.91$1.8252,405,200
$1.91-0.02-1.0%$1.92$1.95$1.89701,500
$1.93-0.03-1.5%$1.96$1.995$1.901,180,100
$1.96-0.02-1.0%$1.98$1.99$1.881,467,300
$1.98+0.05+2.6%$1.96$2.00$1.922,030,300
$1.93+0.04+2.1%$1.905$1.96$1.872,291,800
$1.89+0.05+2.7%$1.84$1.92$1.804,223,400
$1.84-0.01-0.5%$1.83$1.89$1.812,269,500
$1.85+0.04+2.2%$1.81$1.88$1.802,207,700
$1.81-0.08-4.2%$1.88$1.93$1.811,993,800
$1.89-0.01-0.5%$1.89$1.915$1.804,080,100
$1.90-0.04-2.1%$1.91$1.94$1.8552,351,400
$1.94+0.06+3.2%$1.88$1.95$1.882,186,100
$1.88-0.02-1.1%$1.88$1.92$1.862,141,300
$1.90+0.04+2.2%$1.92$1.97$1.857,081,300
$1.86+0.04+2.2%$1.89$1.94$1.813,565,100
$1.82-0.01-0.5%$1.88$1.93$1.8152,285,900
$1.83-0.03-1.6%$1.85$1.87$1.811,641,600
$1.860.000.0%$1.84$1.89$1.832,007,100
$1.86-0.09-4.6%$1.99$1.999$1.862,724,600
$1.95-0.18-8.5%$2.13$2.14$1.954,190,500
$2.13+0.15+7.6%$2.06$2.22$2.049,175,100
$1.98+0.04+2.1%$1.95$2.18$1.9357,753,600
$1.94+0.16+9.0%$1.815$1.955$1.804,542,500
$1.78-0.07-3.8%$1.99$2.04$1.7714,092,400
$1.85+0.05+2.8%$1.81$1.85$1.7713,702,000
$1.80-0.04-2.2%$1.79$1.85$1.774,293,900
$1.84-0.29-13.6%$2.105$2.11$1.7317,237,400
$2.13-0.06-2.7%$2.16$2.29$2.122,807,600
$2.19+0.07+3.3%$2.13$2.23$2.102,647,600
$2.12-0.20-8.6%$2.29$2.38$2.125,148,400
$2.32+0.47+25.4%$2.08$2.43$2.0814,445,470
$1.85+0.10+5.7%$1.70$1.90$1.6916,274,388
$1.75-0.03-1.7%$1.81$1.84$1.7254,179,600
$1.78-0.12-6.3%$1.86$1.88$1.764,099,000
$1.90+0.20+11.8%$1.75$1.96$1.7011,930,800
$1.70-0.01-0.6%$1.68$1.73$1.5913,374,300
$1.71-0.09-5.0%$1.755$1.925$1.709,894,000
$1.80-0.03-1.6%$1.77$1.87$1.715,842,400
$1.83+0.11+6.4%$1.70$1.92$1.7010,638,700
$1.72+0.10+6.2%$1.65$1.75$1.5712,540,900
$1.62+0.245+17.8%$1.435$1.84$1.4332,913,500
$1.375-12.07-89.8%$1.79$1.83$1.3165,534,700
$13.44+0.13+1.0%$13.50$14.25$13.102,094,800
$13.31+0.26+2.0%$12.99$13.60$12.991,191,900
Ticker
NASDAQ:TENX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Tenax Therapeutics (NASDAQ:TENX) Q3 2025 Earnings Call

    Thu, Nov 13, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

All Tenax Therapeutics, Inc. news

Financings

  • Private placement of common stock and pre-funded warrants

    Mar 5, 2025

    Announced: about US$25M · US$6.04 a share · Leerink Partners +2

    Dealers: Leerink Partners (lead), Guggenheim Securities (co-lead), William Blair (co-lead)

    Buyers: RTW Investments (approximately $25 million of common stock and pre-funded warrants)

    Use of proceeds: Advance ongoing and planned Phase 3 clinical trials, working capital, capital expenditures and general corporate purposes

    Announced Mar 5, 2025

Read by 6ix AI from the company's releases

Decks

Tenax Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 83 in all · newest Nov 5, 2026 · oldest 2019
Calls
1 call with a replay · 1 with a transcript · latest Nov 13, 2025
Decks
14 decks · latest Oct 8, 2026

Where Tenax Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TENX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:TENXBOATSUnited StatesUSD
Frankfurt:YBO0FrankfurtGermanyEUR
gettex:YBO0gettexGermanyEUR
Lang & Schwarz:A3EVQNLang & SchwarzGermanyEUR

Log in to ask 6ix AI your own questions about Tenax Therapeutics, Inc.